Crossroads Treatment Centers
Crossroads Treatment Centers is a PE-backed outpatient provider of medication-assisted treatment for opioid and alcohol use disorders, operating 100+ centers across 9 states and serving 26,000+ patients per month.
- Company typePrivate
- Founded2005
- HeadquartersGreenville, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
Crossroads Treatment Centers firmographics
Firmographics- Name
- Crossroads Treatment Centers
- Legal name
- Crossroads Treatment Centers
- Website
- https://crossroadstreatmentcenters.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Crossroads Treatment Centers is a PE-backed outpatient provider of medication-assisted treatment for opioid and alcohol use disorders, operating 100+ centers across 9 states and serving 26,000+ patients per month.
- Ownership category
- akta.pro rank
Crossroads Treatment Centers industry classification
Industry- Product category
- Outpatient Substance Use Disorder Treatment
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)
- akta.pro secondary industries
- Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG), Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD), Substance Use Recovery & Harm Reduction Support Services (BPAGAEAO), Psychiatry & Medication Management Platforms (HLALAEAB)
Keywords
Where Crossroads Treatment Centers is headquartered
LocationHeadquarters
- HQ city
- Greenville
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Crossroads Treatment Centers business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Outpatient Treatment Services: Crossroads generates revenue through outpatient medication-assisted treatment services for opioid and alcohol use disorders. Services are billed through insurance, Medicaid, and other payer sources. The company provides comprehensive care coordination and counseling as part of the treatment model.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
Crossroads Treatment Centers product offering
Product offeringCore offering
Crossroads Treatment Centers operates outpatient substance use disorder treatment programs delivering medication-assisted treatment (MAT) using FDA-approved medications such as methadone and buprenorphine/Suboxone for opioid use disorder and alcohol use disorder. Services are delivered through a national network of 100+ clinics across nine states, supplemented by mobile treatment units, telehealth, and branded intake processes (Instant Intake®), with revenue generated from insurance, Medicaid, and other payer reimbursements.
Product overview
Crossroads Treatment Centers operates as a unified outpatient treatment platform offering medication-assisted treatment (MAT) for substance use disorders, with over 100 locations across 9 states. The core offering centers on FDA-approved medications (methadone, buprenorphine/Suboxone) combined with counseling and behavioral health therapies. Key integrated services include Instant Intake (same-day/virtual appointments), Holly (digital scheduling assistant), Care Coordination, Peer Support, and specialty programs like the Soft Re-Entry Program for justice-involved individuals and Mobile Treatment Units for rural communities. The company also provides a Community Health Program addressing social determinants of health, and has implemented Measurement-Based Care frameworks for outcomes tracking.
Differentiator
Problem solved
Functional benefit
Brands
- Instant Intake: Same-day and virtual intake service allowing patients to quickly access treatment through virtual appointments or same-day in-person scheduling.
- Soft Re-Entry Program
- Community Health Program
Products and services
- Outpatient Opioid Use Disorder Treatment Outpatient medication-based recovery program for adults with opioid use disorder, combining FDA-approved MAT with counseling, care coordination, and peer support so patients can maintain daily routines during treatment.
- Alcohol Use Disorder Treatment Outpatient treatment services for individuals with alcohol use disorder, providing medication-based recovery support and counseling to manage dependency and prevent relapse.
- Medication-Assisted Treatment (MAT) Evidence-based medication-assisted treatment program using FDA-approved medications including methadone and buprenorphine/Suboxone for opioid use disorder and selected medications for alcohol use disorder, integrated with counseling.
- Instant Intake® Same-day and virtual intake service offering new patients rapid access to opioid or alcohol use disorder treatment, including bridge prescriptions while awaiting in-person appointments.
- Mobile Treatment Unit Mobile unit delivering medication-assisted treatment, counseling, and recovery support directly to underserved rural communities that lack access to fixed treatment centers.
- Soft Re-Entry Program Specialized program supporting justice-involved individuals with SUDs as they transition from incarceration back into the community, providing peer support, care management, and a warm handoff into treatment to address the elevated post-release overdose risk.
- Community Health Program Philadelphia-based community health program addressing opioid use disorder under Pennsylvania's Centers of Excellence initiative; identifies and mitigates social determinants of health using the University of Pennsylvania's IMPaCT community health worker model.
- Telehealth / Virtual Appointments Virtual visit option enabling patients to access intake and ongoing SUD treatment remotely via video appointments, supporting 24/7 access to care.
Quantifiable outcome
- 90%+ patients achieve full remission at 12 months of treatment
- +5 more outcomes
Companies that use Crossroads Treatment Centers
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
Crossroads Treatment Centers technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Crossroads Treatment Centers partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered major and minor.
- Vaya HealthmajorNorth Carolina managed care organization supporting the mobile addiction treatment unit initiative in rural Western North Carolina. Vaya Health provides funding and partnership support for the mobile unit serving a 40-mile radius of Weaverville.
- Newdale ChurchmajorLocal church in Western North Carolina serving as community host partner for Crossroads' mobile addiction treatment unit. The church partnership addresses transportation and access barriers while reducing stigma for rural patients seeking treatment.
- North Carolina Department of Health and Human ServicesmajorState government agency supporting the mobile addiction treatment initiative through funding and policy backing for expanding SUD treatment access in Western North Carolina communities impacted by Hurricane Helene.
- Family Health ServicesmajorPennsylvania-based outpatient addiction treatment provider acquired by Crossroads in July 2025. The acquisition expanded Crossroads' operational footprint in Pennsylvania with locations in New Kensington and Ford City, enhancing treatment access in high-overdose areas.
- Dr. Jerome AdamsminorFormer 20th U.S. Surgeon General and member of the White House Coronavirus Task Force added to Crossroads Treatment Centers board to help guide treatment initiatives.
- University of Pennsylvania Health SystemminorResearch and program development partner for the Crossroads Community Health Program. UPenn researchers worked with Philadelphia community members and health system leadership to develop the IMPaCT model-based community health program.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Crossroads Treatment Centers competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key highlights7 records
Customer concentration
Crossroads Treatment Centers social profiles
Digital presenceCrossroads Treatment Centers compliance and trust
Trust signalCompliance2 records
Crossroads Treatment Centers financial estimates
Financial estimateRevenue estimate
Valuation estimate
Crossroads Treatment Centers leadership team
Management profileNumber of profiles
Profiles9 records
Crossroads Treatment Centers subsidiaries and ownership
Company hierarchySubsidiaries1 record
Crossroads Treatment Centers funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Crossroads Treatment Centers M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Crossroads Treatment Centers
What does Crossroads Treatment Centers do?
Crossroads Treatment Centers operates outpatient substance use disorder treatment programs delivering medication-assisted treatment (MAT) using FDA-approved medications such as methadone and buprenorphine/Suboxone for opioid use disorder and alcohol use disorder. Services are delivered through a national network of 100+ clinics across nine states, supplemented by mobile treatment units, telehealth, and branded intake processes (Instant Intake®), with revenue generated from insurance, Medicaid, and other payer reimbursements.
Is Crossroads Treatment Centers a public or private company?
Crossroads Treatment Centers is a private company. It is classified as private equity controlled and is currently operating.
When was Crossroads Treatment Centers founded?
Crossroads Treatment Centers was founded in 2005. It employs 501 to 1,000 people.
Where is Crossroads Treatment Centers based?
Crossroads Treatment Centers is headquartered in Greenville, United States, in the North America region.
How does Crossroads Treatment Centers make money?
One revenue line is on record: outpatient Treatment Services.
Does Crossroads Treatment Centers have an API?
No public API is recorded for Crossroads Treatment Centers.
What industry is Crossroads Treatment Centers in?
Crossroads Treatment Centers's product category is Outpatient Substance Use Disorder Treatment. Its primary akta.pro industry code is HLAFACAF, Outpatient Substance Use Treatment Programs (IOP/PHP/OP), with a secondary code of HLAFACAG, Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs). Its NAICS code is 621420 and its SIC code is 8093.